Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Building Data Infrastructure For PCORI Research Should Start Now, NIH’s Collins Says

Executive Summary

NIH Director Collins, a member of the Patient-Centered Outcomes Research Institute board of governors, offered his vision of a data infrastructure that would enable PCORI to maximize its research capabilities while minimizing costs of conducting research. At the same PCORI-sponsored workshop, Institute Executive Director Joe Selby described the main characteristics a national data infrastructure should offer.

You may also be interested in...



PCORI To Fund Development Of Data Networks For Comparative Effectiveness Research

The Patient-Centered Outcomes Research Institute plans up to $68 million in grants to develop two types of national data networks: clinical data research networks and patient-powered research networks.

PCORI To Fund Development Of Data Networks For CER, Clinical Development

Patient-Centered Outcomes Research Institute plans up to $68 million in grants to develop two types of national data infrastructure, one aimed at clinical data research networks and the other at patient-powered research networks, that together can help researchers across all spectrums of health care develop robust comparative health care data.

PCORI Critics Emerge As Institute Formally Releases Draft Methods Report

As the Patient-Centered Outcomes Research Institute opens the public comment period for its draft methodology report, criticisms on the institute's direction are beginning to surface, including accusations that it is becoming just another AHRQ or NIH.

Related Content

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

PS054588

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel